Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Community-acquired pneumonia].

P Léophonte, L Larios-Ramos, R M Rouquet

    La Revue Du Praticien
    |June 8, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Community-acquired pneumonia (CAP) treatment is empirical due to diagnostic challenges. Penicillin A is recommended for typical CAP, while macrolides are preferred for atypical pneumonia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Profile of smoking dependency in hidradenitis suppurativa patients and smoking cessation outcomes.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Practical guidelines on e-cigarettes for practitioners and others health professionals. A French 2016 expert's statement.

    Revue des maladies respiratoires·2017
    Same author

    [Home telemonitoring of lung-transplanted patients: A feasibility study].

    Revue des maladies respiratoires·2014
    Same author

    [Evaluation of a manual CPAP home telemonitoring device to an automatic one].

    Revue des maladies respiratoires·2014
    Same author

    [Telemedicine and lung transplanted patients: A feasibility study].

    Revue des maladies respiratoires·2014
    Same author

    [Impact of facial versus nose mask on the length of use of CPAP in patients with Sleep Apnea Syndrome?].

    Revue des maladies respiratoires·2013
    Same journal

    [Prolonged fever].

    La Revue du praticien·2026
    Same journal

    [Lower gastrointestinal bleeding].

    La Revue du praticien·2026
    Same journal

    [Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

    La Revue du praticien·2026
    Same journal

    [A history of child abuse intervention in the West].

    La Revue du praticien·2026
    Same journal

    [Agranulocytose médicamenteuse].

    La Revue du praticien·2026
    Same journal

    [Patient education in heart failure].

    La Revue du praticien·2026
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Pharmacology

    Context:

    • Community-acquired pneumonia (CAP) is a significant global health concern, representing a substantial portion of lower respiratory infections.
    • Annual incidence rates vary, with 1-10 cases per 1,000 adults, influenced by geographical and temporal factors.
    • Current diagnostic limitations necessitate empirical treatment strategies for CAP.

    Purpose:

    • To outline evidence-based antibiotic treatment guidelines for community-acquired pneumonia.
    • To identify key causative microorganisms and their antibiotic sensitivities.
    • To provide a framework for selecting appropriate antimicrobial therapy based on clinical presentation and suspected pathogens.

    Summary:

    • Empirical antibiotic selection for CAP relies on epidemiological data, clinical presentation, and known bacterial resistance patterns.

    Related Experiment Videos

  • Key pathogens include Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, and Legionella pneumophila.
  • Penicillin A is the initial choice for typical pneumonia targeting S. pneumoniae and H. influenzae; macrolides are preferred for atypical pneumonia (M. pneumoniae, L. pneumophila).
  • Concomitant penicillin and macrolide therapy is advised for severe or worsening pneumonia in debilitated patients.

    • Impact:

    • Optimized antibiotic selection can improve patient outcomes and reduce the development of antimicrobial resistance.
    • Standardized treatment protocols aid clinicians in managing CAP effectively.
    • Highlights the need for improved, accessible diagnostic methods for prompt and accurate identification of CAP pathogens.